News

Patients in the U.S. with chronic obstructive pulmonary disease (COPD) or other respiratory conditions may now have their own AirPhysio device from Life Wellness Healthcare delivered to their homes, thanks to an update the company made to its online store. This update will allow patients to order the…

Standardized questionnaires can effectively be used to help diagnose chronic obstructive pulmonary disease (COPD) in settings where healthcare resources may be limited, according to a new study. The study, “Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings,” was…

A first patient has been enrolled in a Phase 4 study of the effectiveness of Yupelri (revefenacin) against Spiriva (tiotropium) in improving lung health in adults with severe chronic obstructive pulmonary disease (COPD). The respective safety of these two approved, once-daily COPD maintenance treatments will also be evaluated. Yupelri, developed…

Adults with chronic obstructive pulmonary disease (COPD) are being recruited for a study into whether Wellinks’ first integrated virtual management system solution for COPD can improve patient outcomes. The 24-week study is being conducted in partnership with the COPD Foundation, and it intends to enroll between 100…

A Chinese remedy called Xuanbai Chengqi decoction, or XBCQ, used to treat chronic obstructive pulmonary disease (COPD), modulated immune cells, improved lung function, and reduced lung inflammation by potentially changing the gut microbiome of mice with the disease, a study suggested. “XBCQ could alleviate COPD exacerbations by reshaping the gut…

An international team of researchers has published a new framework, dubbed the Rome proposal, for defining and classifying exacerbations of chronic obstructive pulmonary disease (COPD). “The ‘Rome Proposal’ represents an important milestone for better understanding and treating a very important and troubling component of COPD progression and, the prospect…

The method used for assessing the severity of chronic obstructive pulmonary disease (COPD) and diagnosing other lung diseases should be made race-neutral, as opposed to the current one that includes racial adjustments in defining normal lung function, according to a recent study. The study found no differences in event…

NuvoAir Aos, a sensor developed by NuvoAir that can track how inhalers are used by people with chronic obstructive pulmonary disease (COPD) or asthma, is now available in Europe, the company announced. The sensor is designated a Class I medical device in Europe, essentially indicating that it is…

A single alteration in the sequence of the CHRNA5 gene that leads to inflammation, tissue remodeling, and abnormal repair of airway cells was found, in a recent study, to be a risk factor for chronic obstructive pulmonary disease (COPD). Notably, this gene variant is involved in nicotine-responding/dependent pathways, but was…

An anti-inflammatory compound used in China to help treat liver disease — known as magnesium isoglycyrrhizinate (MgIG) — eased the symptoms of chronic obstructive pulmonary disease (COPD) by reducing inflammation in the lungs, a study in a rat disease model reported. “These findings suggest MgIG might be an alternative for…